| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Codexis, Inc. (CDXS) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. CDXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 727.1K | $1.72M | - | |
| CEO | 254.3K | $602.8K | - | |
| 10% | 180.0K | $426.6K | - | |
| ? | 139.0K | $329.3K | - | |
| Other | 138.8K | $328.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2018 | Nicols John J86 | President And CEO | Sale+OE | 43,812 | $21.78 | $954,041.37 | -2.0% | |
| Nov 13, 2018 | Lalonde James | SVP, R&D | Sell | 13,453 | $15.40 | $207,111.12 | -4.2% | |
| Oct 3, 2018 | Sangster Gordon | SVP &Chief Financial Officer | Sale+OE | 80,000 | $16.94 | $1,354,991.79 | -15.7% | |
| Sep 28, 2018 | Nicols John J86 | President And CEO | Sale+OE | 80,000 | $17.57 | $1,405,672.63 | -2.4% | |
| Sep 27, 2018 | Baruch Thomas R | Director | Sell | 25,000 | $18.54 | $463,392.67 | -5.9% | |
| Sep 26, 2018 | Wolf Dennis P77 | Director | Sell | 9,000 | $19.17 | $172,521.90 | -8.6% | |
| Sep 25, 2018 | Glaub Kathleen Sereda | Director | Sell | 14,492 | $18.83 | $272,816.25 | -18.6% | |
| Sep 21, 2018 | Kelley Bernard J | Director | Sell | 10,207 | $18.12 | $184,959.01 | -4.5% | |
| Sep 19, 2018 | Glaub Kathleen Sereda | Director | Sell | 20,094 | $17.94 | $360,389.91 | -20.5% | |
| Sep 19, 2018 | Yang Patrick Y72 | Director | Sell | 50,000 | $18.20 | $910,177.50 | -17.7% |